Lynparza 150Mg Tablet Substitute
Intas Pharmaceuticals Ltd
₹5812.5
(₹193.75 per unit)
Adley Formulations
₹12938
(₹215.63 per unit)
Dr Reddy's Laboratories Ltd
₹2187
(₹218.7 per unit)
Dr Reddy's Laboratories Ltd
₹13125
(₹218.75 per unit)
Glenmark Pharmaceuticals Ltd
₹13232
(₹220.53 per unit)
Zydus Healthcare Ltd
₹14057.5
(₹234.29 per unit)
Lucien Life Sciences
₹7031
(₹234.37 per unit)
Natco Pharma Ltd
₹7453
(₹248.43 per unit)
Medion Biotech Pvt Ltd
₹16000
(₹266.67 per unit)
Hetero Healthcare Pvt Ltd
₹8447
(₹281.57 per unit)
Eris Life Sciences Ltd
₹18843.5
(₹314.06 per unit)
MEDICAMEN BIOTECH LTD
₹25200
(₹420.0 per unit)
Symbion Lifescience
₹46500
(₹775.0 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹25312
(₹904.0 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹50625
(₹904.02 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Lynparza 150Mg Tablet to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - OLAPARIB-150MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Lynparza 150Mg Tablet is used in the treatment of Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. The detailed uses of Lynparza 150Mg Tablet are as follows:
Lynparza 150Mg Tablet belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate. Lynparza 150Mg Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
RX